MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/ccid.s449367

Медицинская библиотека · Clinical, cosmetic and investigational dermatology · 2024

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study.

Martora Fabrizio, Marasca Claudio, Cacciapuoti Sara, Fariello Federica, Potestio Luca, Battista Teresa, Scalvenzi Massimiliano, Megna Matteo

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The treatment of hidradenitis suppurativa (HS) has always been a real challenge for dermatologists; to date, adalimumab the only biologic drug approved for HS is adalimumab, an anti-tumor necrosis factor (TNF)-α drug, the approval of this drug dates to 2015, data provided by real life show an effectiveness rate of about 60% percent. Recently (31 October 2023) FDA approves secukinumab for moderate-severe HS. The treatment and management of HS is very challenging as available treatments are very limited and show very variable outcomes.

METHODS

We conducted a prospective monocentric study designed to evaluate the efficacy and safety of secukinumab treatment in HS patients in a real-life setting.

RESULTS

The initial cohort of patients recruited included 21 HS patients including 12 females and 9 males. About 57.1% of patients achieved the primary endpoint and recorded significant decrease in all the severity assessment scales (IHS4, DLQI and VAS pain scale) at week 16 and 52, when HiSCR reached 71.4%.

CONCLUSION

The results of our study highlight that treatment with secukinumab in patients with severe HS who failed adalimumab may be a safe and effective therapeutic weapon.

Для цитирования: Martora Fabrizio, Marasca Claudio, Cacciapuoti Sara, Fariello Federica, Potestio Luca, Battista Teresa, Scalvenzi Massimiliano, Megna Matteo. Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study.. Clinical, cosmetic and investigational dermatology. 2024. DOI: 10.2147/ccid.s449367.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.